Case number 2016-1678
Novartis AG v. Noven Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | NOVARTIS AG v. NOVEN PHARMACEUTICALS INC. [OPINION] [precedential] (0) |
| May 26, 2017 | 80 | Mandate issued to the United States Patent and Trademark Office. Costs taxed in the amount of $367.60. Service as of this date by Clerk of Court. [434438] [16-1678, 16-1679] [JAB] [Entered: 05/26/2017 11:54 AM] (0) |
| Apr 18, 2017 | 79 | Bill of Costs for Appellee Noven Pharmaceuticals Inc.. Service: 04/18/2017 by email. Objection to Bill of Costs due on 05/05/2017. [425275] [Michael Levy] [Entered: 04/18/2017 04:30 PM] (0) |
| Apr 4, 2017 | 78 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Prost,Chief Judge; Wallach,Circuit Judge and Stoll,Circuit Judge). [421156] [16-1678, 16-1679] [JAB] [Entered: 04/04/2017 09:36 AM] (0) |
| Mar 13, 2017 | 76 | Submitted after ORAL ARGUMENT by Charlotte Jacobsen for Novartis AG and LTS Lohmann Therapie-Systeme AG and Frances Lynch for Lee. Panel: Judge: Prost , Judge: Wallach , Judge: Stoll. [414792] [JAB] [Entered: 03/13/2017 12:18 PM] (0) |
| Mar 13, 2017 | 77 | ORDER filed granting motion to withdraw party [74] filed by Appellee Mylan Pharmaceuticals Inc. The revised official caption is reflected in the order. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [414830] [JCA] [Entered: 03/13/2017 01:17 PM] (0) |
| Mar 9, 2017 | 74 | MOTION of Appellee Mylan Pharmaceuticals Inc. to withdraw party, Mylan Pharmaceuticals Inc., as a party to this appeal. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/09/2017 by email. [413995] [Michael Rosato] [Entered: 03/09/2017 02:56 PM] (0) |
| Mar 9, 2017 | 75 | AMENDED Response to oral argument order from the Appellee Noven Pharmaceuticals Inc.. waiving oral argument. Service of other counsel by Notice of Docket Activity from this entry. [414119] [Michael Levy] [Entered: 03/09/2017 04:29 PM] (0) |
| Feb 16, 2017 | 72 | Entry of appearance for Richard Torczon as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/16/2017 by email. [408332] [Michael Rosato] [Entered: 02/16/2017 04:05 PM] (0) |
| Feb 16, 2017 | 73 | Amended Certificate of Interest for the Appellee Mylan Pharmaceuticals Inc.. Service: 02/16/2017 by email. [408336] [Michael Rosato] [Entered: 02/16/2017 04:09 PM] (0) |
| Feb 15, 2017 | 71 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account of Mr. Christopher Justin Coulson for Noven Pharmaceuticals Inc. The e-mail address, (bpound@kenyon.com), associated with your CM/ECF account has generated a delivery failure notice. Counsel should promptly report a change in contact information with the Pacer Service Center (see Fed. Cir. R. 47.3(c)(1). [407921] [PMM] [Entered: 02/15/2017 04:22 PM] (0) |
| Feb 15, 2017 | 70 | Response to oral argument order from the Intervenor Lee. designating Frances M. Lynch as arguing attorney. Designated time for argument: 4 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [407690] [Frances Lynch] [Entered: 02/15/2017 12:03 PM] (0) |
| Feb 14, 2017 | 69 | Response to oral argument order from the Appellees Mylan Pharmaceuticals Inc. and Noven Pharmaceuticals Inc.. designating Michael K. Levy as arguing attorney. Designated time for argument: 11 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [407471] [Michael Levy] [Entered: 02/14/2017 05:33 PM] (0) |
| Feb 14, 2017 | 68 | Response to oral argument order from the Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. designating Charlotte Jacobsen as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [407409] [Jared Stringham] [Entered: 02/14/2017 03:45 PM] (0) |
| Jan 23, 2017 | 67 | NOTICE OF CALENDARING. Panel: 1703R. Case scheduled Mar 13, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 203. Response to oral argument order due: 02/15/2017. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [400931] THIS NOTICE APPLIES TO CASE(S): [16-1332, 16-2105, 16-1678, 16-2122] [JAB] [Entered: 01/23/2017 03:51 PM] (0) |
| Dec 14, 2016 | 66 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [390863] [JCA] [Entered: 12/14/2016 10:32 AM] (0) |
| Oct 27, 2016 | 65 | Notice from Appellee Noven Pharmaceuticals Inc. regarding conflicts with oral argument (None.). Service: 10/27/2016 by email. [378105] [Steven Lee] [Entered: 10/27/2016 02:56 PM] (2) |
| Oct 27, 2016 | 64 | Notice from Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG regarding conflicts with oral argument (January 9-13, 2017). Service: 10/27/2016 by email. [378094] [Charlotte Jacobsen] [Entered: 10/27/2016 02:27 PM] (2) |
| Oct 24, 2016 | 63 | 6 paper copies of the Confidential Joint Appendix (Vol. I-III) [60] received from Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. [377302] [KW] [Entered: 10/25/2016 09:05 AM] (0) |
| Oct 20, 2016 | 62 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 10/27/2016. [376127] [JCA] [Entered: 10/20/2016 09:46 AM] (0) |
| Oct 19, 2016 | 61 | APPENDIX FILED for LTS Lohmann Therapie-Systeme AG and Novartis AG [59]. Number of Pages: 1487. Service: 10/19/2016 by email. [376123] [JCA] [Entered: 10/20/2016 09:42 AM] (1487) |
| Oct 19, 2016 | 60 | CONFIDENTIAL JOINT APPENDIX FILED for LTS Lohmann Therapie-Systeme AG and Novartis AG [58]. Number of Pages: 1514. Service: 10/19/2016 by email. The paper copies of the brief should be received by the court on or before 10/25/2016. [376117] [JCA] [Entered: 10/20/2016 09:35 AM] (0) |
| Oct 19, 2016 | 59 | TENDERED from Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. Title: JOINT APPENDIX. Service: 10/19/2016 by email. [375890] [Jared Stringham] [Entered: 10/19/2016 02:00 PM] (1487) |
| Oct 19, 2016 | 58 | TENDERED from Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. Title: CONFIDENTIAL JOINT APPENDIX Service: 10/19/2016 by email. [375885] [Jared Stringham] [Entered: 10/19/2016 01:53 PM] (0) |
| Oct 14, 2016 | 57 | 6 paper copies of the Reply Brief [56] received from Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. [374649] [KW] [Entered: 10/17/2016 09:17 AM] (0) |
| Oct 12, 2016 | 56 | REPLY BRIEF FILED for Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG [55]. Number of Pages: 34. Service: 10/12/2016 by email. The paper copies of the brief should be received by the court on or before 10/17/2016. Appendix is due 10/19/2016. [373638] [JCA] [Entered: 10/12/2016 03:58 PM] (46) |
| Oct 12, 2016 | 55 | TENDERED from Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. Title: REPLY BRIEF. Service: 10/12/2016 by email. [373569] [Charlotte Jacobsen] [Entered: 10/12/2016 02:21 PM] (46) |
| Sep 30, 2016 | 54 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [53], attorney entry of appearance Docket No. [52], attorney entry of appearance Docket No. [51], attorney entry of appearance Docket No. [49], ERROR: The firm name listed on these entry of appearance forms does not match what we have in our database. CORRECTION: Update your firm name with the PACER service center if you have not done so already. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [370494] [JCA] [Entered: 09/30/2016 11:34 AM] (0) |
| Sep 29, 2016 | 53 | Amended Entry of appearance for Kulsoom Hasan as of counsel for Appellee Noven Pharmaceuticals Inc.. Service: 09/29/2016 by email. [370345] [Kulsoom Hasan] [Entered: 09/29/2016 04:47 PM] (2) |
| Sep 29, 2016 | 52 | Amended Entry of appearance for Christopher J. Coulson as of counsel for Appellee Noven Pharmaceuticals Inc.. Service: 09/29/2016 by email. [370344] [Christopher Coulson] [Entered: 09/29/2016 04:45 PM] (2) |
| Sep 29, 2016 | 51 | Amended Entry of appearance for Michael K. Levy as of counsel for Appellee Noven Pharmaceuticals Inc.. Service: 09/29/2016 by email. [370343] [Michael Levy] [Entered: 09/29/2016 04:43 PM] (2) |
| Sep 29, 2016 | 50 | Amended Certificate of Interest for the Appellee Noven Pharmaceuticals Inc.. Service: 09/29/2016 by email. [370341] [Steven Lee] [Entered: 09/29/2016 04:40 PM] (2) |
| Sep 29, 2016 | 49 | Amended Entry of appearance for Steven J. Lee as principal counsel for Appellee Noven Pharmaceuticals Inc.. Service: 09/29/2016 by email. [370340] [Steven Lee] [Entered: 09/29/2016 04:39 PM] (2) |
| Aug 24, 2016 | 48 | ORDER filed. The motion [46] is granted to the extent that Appellants' reply brief is due no later than October 12, 2016. Service: 08/24/2016 by clerk. [361470] [LMS] [Entered: 08/24/2016 08:55 AM] (2) |
| Aug 23, 2016 | 47 | RESPONSE of Appellee Noven Pharmaceuticals Inc. to the motion to extend time to file reply brief [46] filed by Appellants Novartis AG and LTS Lohmann Therapie-Systeme AG in 16-1678. Service: 08/23/2016 by email. [361158] [Michael Levy] [Entered: 08/23/2016 10:14 AM] (6) |
| Aug 18, 2016 | 46 | MOTION of Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG to extend the time to 10/11/2016 to file the reply brief. Response/Opposition is due 08/29/2016 [Consent: partial consent]. Service: 08/18/2016 by email. [359970] [Charlotte Jacobsen] [Entered: 08/18/2016 01:35 PM] (10) |
| Aug 10, 2016 | 44 | 6 paper copies of the Intervenor Brief [41] received from Intervenor Lee. [357752] [KW] [Entered: 08/10/2016 03:16 PM] (0) |
| Aug 10, 2016 | 45 | 6 paper copies of the Confidential Response Brief [42] received from Appellees Mylan Pharmaceuticals Inc. and Noven Pharmaceuticals Inc. [357754] [KW] [Entered: 08/10/2016 03:24 PM] (0) |
| Aug 8, 2016 | 38 | TENDERED from Appellees Mylan Pharmaceuticals Inc. and Noven Pharmaceuticals Inc.. Title: RESPONSE BRIEF. Service: 08/08/2016 by email. [356986] [Michael Levy] [Entered: 08/08/2016 03:39 PM] (73) |
| Aug 8, 2016 | 43 | BRIEF FILED for Appellees Mylan Pharmaceuticals Inc. and Noven Pharmaceuticals Inc. [38]. Number of Pages: 57. Service: 08/08/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the confidential brief in paper format. The paper copies of the brief should be received by the court on or before 08/15/2016. Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG reply brief is due 08/25/2016. [357276] [JCA] [Entered: 08/09/2016 11:42 AM] (73) |
| Aug 8, 2016 | 42 | CONFIDENTIAL BRIEF FILED for Appellees Mylan Pharmaceuticals Inc. and Noven Pharmaceuticals Inc. [39]. Number of Pages: 57. Service: 08/08/2016 by email. Pursuant to Fed. Cir. R. 28(d)(2)(A) six paper copies should be filed of the confidential version only. [357274] [JCA] [Entered: 08/09/2016 11:40 AM] (0) |
| Aug 8, 2016 | 41 | BRIEF FILED for Intervenor Lee [40]. Number of Pages: 24. Service: 08/08/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 08/15/2016. [357267] [JCA] [Entered: 08/09/2016 11:32 AM] (31) |
| Aug 8, 2016 | 40 | TENDERED from Intervenor Lee. Title: INTERVENOR BRIEF. Service: 08/08/2016 by email. [357049] [Frances Lynch] [Entered: 08/08/2016 04:35 PM] (31) |
| Aug 8, 2016 | 39 | TENDERED from Appellees Mylan Pharmaceuticals Inc. and Noven Pharmaceuticals Inc.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 08/08/2016 by email. [356988] [Michael Levy] [Entered: 08/08/2016 03:40 PM] (0) |
| Jul 25, 2016 | 37 | Docketing Statement for the Intervenor Lee. Service: 07/25/2016 by email. [353284] [Frances Lynch] [Entered: 07/25/2016 12:07 PM] (3) |
| Jun 30, 2016 | 35 | MOTION of Appellee Noven Pharmaceuticals Inc. to extend the time to 08/08/2016 to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition is due 07/14/2016 [Consent: unopposed]. Service: 06/30/2016 by email. [347822] [Michael Levy] [Entered: 06/30/2016 03:19 PM] (6) |
| Jun 30, 2016 | 36 | **TEXT ONLY** ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [35] filed by Appellee Noven Pharmaceuticals Inc. Appellees Mylan Pharmaceuticals Inc. and Noven Pharmaceuticals Inc. brief due 08/08/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [347850] [JCA] [Entered: 06/30/2016 03:38 PM] (0) |
| Jun 24, 2016 | 31 | Entry of appearance for Nathan K. Kelley as principal counsel for U.S. Patent and Trademark Office. Service: 06/24/2016 by email. [346301] [Nathan Kelley] [Entered: 06/24/2016 11:21 AM] (2) |
| Jun 24, 2016 | 34 | Entry of appearance for Kakoli Caprihan as of counsel for Intervenor Lee. Service: 06/24/2016 by email. [346474] [Kakoli Caprihan] [Entered: 06/24/2016 04:29 PM] (2) |
| Jun 24, 2016 | 33 | Clerk's Note to the File: Docketing Statement due 07/25/2016 for Intervenor Lee. Intervenor brief is due 08/08/2016. [346328] [JCA] [Entered: 06/24/2016 12:01 PM] (0) |
| Jun 24, 2016 | 32 | Entry of appearance for Scott C. Weidenfeller as of counsel for U.S. Patent and Trademark Office. Service: 06/24/2016 by email. [346304] [Scott Weidenfeller] [Entered: 06/24/2016 11:25 AM] (2) |
| Jun 24, 2016 | 30 | Entry of appearance for Frances M. Lynch as of counsel for U.S. Patent and Trademark Office. Service: 06/24/2016 by email. [346300] [Frances Lynch] [Entered: 06/24/2016 11:16 AM] (2) |
| Jun 24, 2016 | 29 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 06/24/2016 by email. [346299] [Frances Lynch] [Entered: 06/24/2016 11:14 AM] (3) |
| May 25, 2016 | 28 | 6 paper copies of the Opening Brief [27] received from Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. [338678] [MJL] [Entered: 05/26/2016 11:18 AM] (0) |
| May 23, 2016 | 27 | BRIEF FILED for Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG [26]. Number of Pages: 66. Service: 05/23/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/31/2016. Brief of Appellees Mylan Pharmaceuticals Inc. and Noven Pharmaceuticals Inc. is due 07/08/2016. [337884] [MJL] [Entered: 05/24/2016 11:01 AM] (214) |
| May 23, 2016 | 26 | TENDERED from Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. Title: OPENING BRIEF. Service: 05/23/2016 by email. [337613] [Charlotte Jacobsen] [Entered: 05/23/2016 03:34 PM] (214) |
| Apr 25, 2016 | 25 | Certificate of Compliance with Fed. Cir. R. 17 (Agency) for Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. Service: 04/25/2016 by email. [329393] [Jared Stringham] [Entered: 04/25/2016 03:48 PM] (4) |
| Apr 25, 2016 | 24 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Noven Pharmaceuticals Inc.. Service: 04/25/2016 by email. [329379] [Michael Levy] [Entered: 04/25/2016 03:30 PM] (4) |
| Apr 13, 2016 | 23 | **TEXT ONLY** ORDER granting motion to extend time to file appellant/petitioner principal brief [22] filed by Appellants Novartis AG and LTS Lohmann Therapie-Systeme AG. Brief due 05/23/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [326039] [JCA] [Entered: 04/13/2016 12:19 PM] (0) |
| Apr 13, 2016 | 22 | MOTION of Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG to extend the time to 05/23/2016 to file the appellant/petitioner's principal brief. Response/Opposition is due 04/28/2016 [Consent: unopposed]. Service: 04/13/2016 by email. [326034] [Charlotte Jacobsen] [Entered: 04/13/2016 11:55 AM] (5) |
| Mar 25, 2016 | 21 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [16], ERROR: The firm name and contact information on your entry of appearance does not match what we have in our database.. CORRECTION: Update your firm name and contact information with the PACER service center immediately.. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [321662] [JCA] [Entered: 03/25/2016 09:11 AM] (0) |
| Mar 24, 2016 | 18 | Entry of appearance for Michael T. Rosato as principal counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 03/24/2016 by email. [321583] [Michael Rosato] [Entered: 03/24/2016 05:53 PM] (2) |
| Mar 24, 2016 | 20 | Certificate of Interest for the Appellee Mylan Pharmaceuticals Inc.. Service: 03/24/2016 by email. [321593] [Michael Rosato] [Entered: 03/24/2016 06:08 PM] (2) |
| Mar 24, 2016 | 19 | Docketing Statement for the Appellee Mylan Pharmaceuticals Inc.. Service: 03/24/2016 by email. [321588] [Michael Rosato] [Entered: 03/24/2016 06:01 PM] (4) |
| Mar 24, 2016 | 17 | Entry of appearance for Andrew S. Brown as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 03/24/2016 by email. [321582] [Michael Rosato] [Entered: 03/24/2016 05:50 PM] (2) |
| Mar 24, 2016 | 16 | Entry of appearance for Steven W. Parmelee as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 03/24/2016 by email. [321581] [Michael Rosato] [Entered: 03/24/2016 05:45 PM] (2) |
| Mar 23, 2016 | 15 | Entry of appearance for Jared L. Stringham as of counsel for Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. Service: 03/23/2016 by email. [321287] [Charlotte Jacobsen] [Entered: 03/23/2016 06:01 PM] (4) |
| Mar 23, 2016 | 14 | Entry of appearance for Christopher E. Loh as of counsel for Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. Service: 03/23/2016 by email. [321286] [Charlotte Jacobsen] [Entered: 03/23/2016 06:00 PM] (4) |
| Mar 23, 2016 | 13 | Entry of appearance for Nicholas N. Kallas as of counsel for Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. Service: 03/23/2016 by email. [321285] [Charlotte Jacobsen] [Entered: 03/23/2016 06:00 PM] (4) |
| Mar 23, 2016 | 12 | Certificate of Interest for the Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. Service: 03/23/2016 by email. [321284] [Charlotte Jacobsen] [Entered: 03/23/2016 05:59 PM] (3) |
| Mar 23, 2016 | 11 | Docketing Statement for the Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. Service: 03/23/2016 by email. [321283] [Charlotte Jacobsen] [Entered: 03/23/2016 05:57 PM] (5) |
| Mar 23, 2016 | 10 | Entry of appearance for Charlotte Jacobsen as principal counsel for Appellants LTS Lohmann Therapie-Systeme AG and Novartis AG. Service: 03/23/2016 by email. [321282] [Charlotte Jacobsen] [Entered: 03/23/2016 05:57 PM] (4) |
| Mar 23, 2016 | 9 | Entry of appearance for Kulsoom Hasan as of counsel for Appellee Noven Pharmaceuticals Inc.. Service: 03/23/2016 by email. [321141] [Kulsoom Hasan] [Entered: 03/23/2016 02:00 PM] (2) |
| Mar 23, 2016 | 8 | Entry of appearance for Christopher J. Coulson as of counsel for Appellee Noven Pharmaceuticals Inc.. Service: 03/23/2016 by email. [321140] [Christopher Coulson] [Entered: 03/23/2016 01:58 PM] (2) |
| Mar 23, 2016 | 7 | Entry of appearance for Michael K. Levy as of counsel for Appellee Noven Pharmaceuticals Inc.. Service: 03/23/2016 by email. [321139] [Michael Levy] [Entered: 03/23/2016 01:55 PM] (2) |
| Mar 23, 2016 | 6 | Docketing Statement for the Appellee Noven Pharmaceuticals Inc.. Service: 03/23/2016 by email. [321134] [Steven Lee] [Entered: 03/23/2016 01:51 PM] (4) |
| Mar 23, 2016 | 5 | Certificate of Interest for the Appellee Noven Pharmaceuticals Inc.. Service: 03/23/2016 by email. [321131] [Steven Lee] [Entered: 03/23/2016 01:49 PM] (2) |
| Mar 23, 2016 | 4 | Entry of appearance for Steven J. Lee as principal counsel for Appellee Noven Pharmaceuticals Inc.. Service: 03/23/2016 by email. [321130] [Steven Lee] [Entered: 03/23/2016 01:47 PM] (2) |
| Mar 14, 2016 | 3 | Note to file: The following cases are associated:16-1678 Lead with 16-1679 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [318459] [16-1678, 16-1679] [JCA] [Entered: 03/14/2016 04:22 PM] (0) |
| Mar 14, 2016 | 2 | ORDER consolidating appeals (16-1678, 16-1679). Service as of this date by Clerk of Court. [318458] [16-1678, 16-1679] [JCA] [Entered: 03/14/2016 04:21 PM] (2) |
| Mar 10, 2016 | 1 | Appeal docketed. Date received: 01/29/2016. [317403] Entry of Appearance due 03/24/2016. Certificate of Interest is due on 03/24/2016. Docketing Statement due 03/24/2016. Appellant/Petitioner's brief is due 05/09/2016. [JCA] [Entered: 03/10/2016 10:22 AM] (137) |
